FDA Inspection
Pfizer, Inc.Pfizer, Inc. – FDA Inspection, Jun 3, 2009
Record Details
This FDA Inspection record concerns Pfizer, Inc., with an inspection on June 3, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Pfizer, Inc.
- Inspection Date
- June 3, 2009
- Product Type
- Drugs
View Company Profile
ID · 00481e63-972f-48ea-a27e-33c20d91d791
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 586238
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.50Ensuring compliance with plan and protocol
- 21 CFR 312.53(a)Investigator selection
- 21 CFR 312.53(d)Selecting monitors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pfizer, Inc.
25| Date | Classification | Office | Project area |
|---|---|---|---|
| October 24, 2025 | Not classified | New England District Office | |
| December 13, 2024 | VAI | New England District Office | Bioresearch Monitoring: Human Drugs |
| August 30, 2024 | Not classified | New England District Office | |
| July 19, 2024 | Not classified | New England District Office | |
| April 19, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Pfizer, Inc.
- FDA Inspection 1284680 - 2025-10-24
- FDA Inspection 1256477 - 2024-12-13
- FDA Inspection 1249289 - 2024-08-30
- FDA Inspection 1230476 - 2024-07-19
- FDA Inspection 1204434 - 2023-04-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.